Small interfering RNA

Last updated on: 18.01.2021

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

One of the most significant advances in recent years has been the discovery of the small (20-30 nucleotide) non-coding RNAs that regulate genes and genomes. This regulation can occur at some of the most important levels of genome function, including RNA processing, chromatin structure, RNA stability, chromosome segregation, transcription and translation.

DefinitionThis section has been translated automatically.

Small interfering RNA, abbreviated siRNA, are small, single- or double-stranded ribonucleic acid molecules of 20 to 25 base pairs in length. They thus belong to the group of small non-coding RNAs that regulate genes and genomes.

LiteratureThis section has been translated automatically.

  1. Aigner A (2007) Nonviral in vivo delivery of therapeutic small interfering RNAs. Curr Opin Mol Ther 9:345-352.
  2. Dana H et al (2017) Molecular Mechanisms and Biological Functions of siRNA. Int J Biomed Sci 13: 48-57.
  3. Guo P et al (2010) Engineering RNA for targeted siRNA delivery and medical application. Adv Drug Deliv Rev 62: 650-666.
  4. Iorns EC et al (2007) Utilizing RNA interference to enhance cancer drug discovery. Nat Rev Drug Discov 6:556-568.
  5. Jeong JH et al (2007) Molecular design of functional polymers for gene therapy. Prog Polym Sc 32:1239-1274.
  6. Juliano R et al (2008) Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res 36:4158-4171.
  7. Santel A et al. (2006) RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Gene Ther. 13:1360-1370.
  8. Wang Y et al. (2010) Nanoparticle-based delivery system for application of siRNA in vivo . Curr Drug Metab 11:182-196.

Last updated on: 18.01.2021